Researchers want dynamic medical and genetic data and people want to participate more directly in research. We have built the heterogeneous platform to allow individuals with genetic data (eg from 23andMe) to create a profile and participate directly in ongoing research projects, controlling when and how their data is shared and used. At the same time, we are working directly with rare disease patients and researchers to generate, store, analyse and share dynamic medical and genetic data used in research and healthcare. We believe that creating a secure, patient-centric marketplace for genetic data will make it easier to conduct genetics research and followup studies not only in healthcare, but for a wide variety of organisations.
News about Heterogeneous
Sano Genetics, supported by Accelerate Cambridge at Cambridge Judge Business School, raises £500,000 seed funding for its 'transparent' medical research platform.